跳至主要内容
临床试验/NCT03071510
NCT03071510已完成不适用

IO-CTNG: A Multi-Centre Evaluation of the Atlas Genetics io® CTNG System Used in Centralised and Point of Care Settings

Binx Health Limited10 个研究点 分布在 1 个国家目标入组 7,128 人开始时间: 2017年5月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
7,128
试验地点
10
主要终点
Diagnostic Accuracy compared to positive Composite Infected Status from comparator devices

研究概览

简要总结

Atlas Genetics io® system results are compared with those obtained from comparator devices.

详细描述

Results from the Atlas Genetics io® system are compared with a Composite Infection Status obtained from testing on three commonly used comparator devices.

This is a prospective, single-arm, multi-centre investigation enrolling up to 12,000 adult participants over 14 years of age who are undergoing testing for the presence of CT/NG.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
14 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Symptomatic and asymptomatic individuals ≥14 years of age

排除标准

  • Treatment with antibiotics known to be effective against Chlamydia trachomatis and/or Neisseria gonorrhoeae within the previous 4 weeks before inclusion in the study.
  • Unable to self-obtain a vaginal swab or urine sample of at least 30 mL

结局指标

主要结局

Diagnostic Accuracy compared to positive Composite Infected Status from comparator devices

时间窗: Up to 7 days

The assessment of the diagnostic accuracy of the study device as compared to positive Composite Infected Status from comparator devices

次要结局

未报告次要终点

研究者

发起方
Binx Health Limited
申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验